These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 2744779)
41. Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction. Löfdahl CG; Andersson L; Bondesson E; Carlsson LG; Friberg K; Hedner J; Hörnblad Y; Jemsby P; Källén A; Ullman A; Werner S; Svedmyr N Eur Respir J; 1997 Nov; 10(11):2474-8. PubMed ID: 9426081 [TBL] [Abstract][Full Text] [Related]
42. Comparative efficacy of oral sustained released bronchodilator in stable asthmatics. Koyande DN; Shah SP; Hingorani M; Ailani RK; Haran A; Kadge KM Indian J Chest Dis Allied Sci; 1993; 35(2):51-7. PubMed ID: 8258465 [TBL] [Abstract][Full Text] [Related]
43. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Saleh TS; Calixto JB; Medeiros YS Br J Pharmacol; 1996 Jun; 118(3):811-9. PubMed ID: 8762112 [TBL] [Abstract][Full Text] [Related]
44. Effects of prednisolone, salbutamol and theophylline on bronchial hyperreactivity and leucocyte chemokinesis in guinea pigs. Llupiá J; Fernández AG; Berga P; Gristwood RW Drugs Exp Clin Res; 1991; 17(8):395-8. PubMed ID: 1822832 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of salmeterol in the treatment of childhood asthma. Tomaç N; Tuncer A; Saraçlar Y; Adalioğlu G Acta Paediatr Jpn; 1996 Oct; 38(5):489-94. PubMed ID: 8942009 [TBL] [Abstract][Full Text] [Related]
47. Effect of salbutamol on the measurement of single-breath diffusing capacity. Yang J; Stanton J; Wang L; Beckert L; Frampton C; Burton D; Swanney MP Respirology; 2013 Nov; 18(8):1223-9. PubMed ID: 23701193 [TBL] [Abstract][Full Text] [Related]
48. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Guyatt GH; Townsend M; Pugsley SO; Keller JL; Short HD; Taylor DW; Newhouse MT Am Rev Respir Dis; 1987 May; 135(5):1069-74. PubMed ID: 3579005 [TBL] [Abstract][Full Text] [Related]
49. Effect of nifedipine on antipyrine and theophylline disposition. Adebayo GI; Mabadeje AF Biopharm Drug Dispos; 1990 Mar; 11(2):157-64. PubMed ID: 2183884 [TBL] [Abstract][Full Text] [Related]
50. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma]. Tsukioka K; Nakamata M; Kondo A; Hashimoto T Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948 [TBL] [Abstract][Full Text] [Related]
51. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease]. Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713 [TBL] [Abstract][Full Text] [Related]
52. A double-blind, placebo-controlled comparison of the efficacy of standard and individually titrated doses of theophylline in patients with chronic asthma. Barlow TJ; Graham P; Harris JM; Hartley JP; Turton CW Br J Dis Chest; 1988 Jul; 82(3):251-61. PubMed ID: 3073805 [TBL] [Abstract][Full Text] [Related]
53. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group. Di Lorenzo G; Morici G; Drago A; Pellitteri ME; Mansueto P; Melluso M; Norrito F; Squassante L; Fasolo A Clin Ther; 1998; 20(6):1130-48. PubMed ID: 9916607 [TBL] [Abstract][Full Text] [Related]
54. [Delayed-release salbutamol, a new beta-mimetic with prolonged action. Results of a comparative study against theophylline L.A]. Brune J; Desfougères JL Allerg Immunol (Paris); 1991 Oct; 23(8):358-64. PubMed ID: 1777051 [TBL] [Abstract][Full Text] [Related]
55. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
56. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG Clin Pharmacol Ther; 1979 Jul; 26(1):16-20. PubMed ID: 445957 [TBL] [Abstract][Full Text] [Related]
57. Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma. Williams PE; Alwazir YA; Routledge PA; Campbell IA Br J Clin Pharmacol; 1986 Oct; 22(4):383-7. PubMed ID: 3768254 [TBL] [Abstract][Full Text] [Related]
58. Formoterol delivered via the dry powder Aerolizer inhaler versus albuterol MDI and placebo in mild-to-moderate asthma: a randomized, double-blind, double-dummy trial. Pleskow W; LaForce CF; Yegen U; Matos D; Della Cioppa G J Asthma; 2003; 40(5):505-14. PubMed ID: 14529100 [TBL] [Abstract][Full Text] [Related]
59. [Theophylline plus salbutamol in chronic bronchial obstruction. The additive effects of combination therapy in comparison with salbutamol monotherapy]. Bossert J; Träger E Fortschr Med; 1989 Apr; 107(11):255-8. PubMed ID: 2659475 [TBL] [Abstract][Full Text] [Related]
60. Efficacy of Salbutamol in Mixed Obstructive and Restrictive Pattern Spirometry. Tuladhar LR; Tamrakar Tuladhar ET Kathmandu Univ Med J (KUMJ); 2017 Oct.-Dec.; 15(60):279-283. PubMed ID: 30580341 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]